nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—UGT1A1—Naltrexone—alcohol dependence	0.273	0.47	CbGbCtD
Regorafenib—CYP2B6—Citalopram—alcohol dependence	0.0699	0.12	CbGbCtD
Regorafenib—ABCB1—Naltrexone—alcohol dependence	0.0541	0.0932	CbGbCtD
Regorafenib—CYP2C9—Disulfiram—alcohol dependence	0.0518	0.0893	CbGbCtD
Regorafenib—CYP2C19—Citalopram—alcohol dependence	0.0444	0.0765	CbGbCtD
Regorafenib—ABCB1—Citalopram—alcohol dependence	0.0359	0.0617	CbGbCtD
Regorafenib—CYP3A4—Disulfiram—alcohol dependence	0.0301	0.0519	CbGbCtD
Regorafenib—CYP3A4—Citalopram—alcohol dependence	0.0215	0.037	CbGbCtD
Regorafenib—International normalised ratio increased—Citalopram—alcohol dependence	0.00812	0.0561	CcSEcCtD
Regorafenib—KIT—seminiferous tubule of testis—alcohol dependence	0.00632	0.043	CbGeAlD
Regorafenib—RET—autonomic nervous system—alcohol dependence	0.00454	0.0309	CbGeAlD
Regorafenib—Hypertensive crisis—Citalopram—alcohol dependence	0.00452	0.0313	CcSEcCtD
Regorafenib—Hypothyroidism—Acamprosate—alcohol dependence	0.00326	0.0226	CcSEcCtD
Regorafenib—Hepatotoxicity—Naltrexone—alcohol dependence	0.00257	0.0177	CcSEcCtD
Regorafenib—Lymphopenia—Citalopram—alcohol dependence	0.00245	0.017	CcSEcCtD
Regorafenib—Dysphonia—Naltrexone—alcohol dependence	0.00241	0.0167	CcSEcCtD
Regorafenib—Hyperbilirubinaemia—Acamprosate—alcohol dependence	0.0023	0.0159	CcSEcCtD
Regorafenib—Hyperuricaemia—Acamprosate—alcohol dependence	0.00226	0.0156	CcSEcCtD
Regorafenib—Musculoskeletal stiffness—Naltrexone—alcohol dependence	0.00221	0.0153	CcSEcCtD
Regorafenib—Gastrooesophageal reflux disease—Naltrexone—alcohol dependence	0.00219	0.0152	CcSEcCtD
Regorafenib—Blood uric acid increased—Acamprosate—alcohol dependence	0.00213	0.0147	CcSEcCtD
Regorafenib—Polyp—Citalopram—alcohol dependence	0.00206	0.0143	CcSEcCtD
Regorafenib—Hypothyroidism—Citalopram—alcohol dependence	0.00196	0.0135	CcSEcCtD
Regorafenib—Cyst—Citalopram—alcohol dependence	0.00188	0.013	CcSEcCtD
Regorafenib—DDR2—adrenal cortex—alcohol dependence	0.00182	0.0124	CbGeAlD
Regorafenib—NTRK1—midbrain—alcohol dependence	0.00175	0.0119	CbGeAlD
Regorafenib—Gastroenteritis—Acamprosate—alcohol dependence	0.00172	0.0119	CcSEcCtD
Regorafenib—FRK—gonad—alcohol dependence	0.00168	0.0114	CbGeAlD
Regorafenib—DDR2—cardiovascular system—alcohol dependence	0.00166	0.0113	CbGeAlD
Regorafenib—Gastroenteritis—Naltrexone—alcohol dependence	0.00162	0.0112	CcSEcCtD
Regorafenib—Myocardial ischaemia—Citalopram—alcohol dependence	0.00156	0.0108	CcSEcCtD
Regorafenib—Hyponatraemia—Acamprosate—alcohol dependence	0.00153	0.0106	CcSEcCtD
Regorafenib—Dysphonia—Citalopram—alcohol dependence	0.00153	0.0106	CcSEcCtD
Regorafenib—Endocrine disorder—Citalopram—alcohol dependence	0.00152	0.0105	CcSEcCtD
Regorafenib—NTRK1—testis—alcohol dependence	0.00146	0.00996	CbGeAlD
Regorafenib—Musculoskeletal stiffness—Citalopram—alcohol dependence	0.0014	0.00968	CcSEcCtD
Regorafenib—Dry skin—Acamprosate—alcohol dependence	0.00139	0.00963	CcSEcCtD
Regorafenib—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00139	0.00961	CcSEcCtD
Regorafenib—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00138	0.00955	CcSEcCtD
Regorafenib—DDR2—digestive system—alcohol dependence	0.00138	0.00939	CbGeAlD
Regorafenib—Hypocalcaemia—Citalopram—alcohol dependence	0.00137	0.00948	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00137	0.00947	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00134	0.00927	CcSEcCtD
Regorafenib—Fatigue—Disulfiram—alcohol dependence	0.00131	0.00904	CcSEcCtD
Regorafenib—Pain—Disulfiram—alcohol dependence	0.0013	0.00897	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.0013	0.00896	CcSEcCtD
Regorafenib—Blood uric acid increased—Citalopram—alcohol dependence	0.00128	0.00884	CcSEcCtD
Regorafenib—FRK—endocrine gland—alcohol dependence	0.00127	0.00865	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00127	0.00877	CcSEcCtD
Regorafenib—EPHX2—adrenal cortex—alcohol dependence	0.00123	0.00837	CbGeAlD
Regorafenib—FRK—testis—alcohol dependence	0.00121	0.00825	CbGeAlD
Regorafenib—Weight decreased—Acamprosate—alcohol dependence	0.00119	0.00822	CcSEcCtD
Regorafenib—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00116	0.00799	CcSEcCtD
Regorafenib—Myocardial infarction—Acamprosate—alcohol dependence	0.00115	0.00794	CcSEcCtD
Regorafenib—FRK—liver—alcohol dependence	0.00115	0.0078	CbGeAlD
Regorafenib—Stomatitis—Acamprosate—alcohol dependence	0.00114	0.0079	CcSEcCtD
Regorafenib—DDR2—endocrine gland—alcohol dependence	0.00114	0.00776	CbGeAlD
Regorafenib—Neoplasm—Citalopram—alcohol dependence	0.00114	0.00785	CcSEcCtD
Regorafenib—Weight decreased—Naltrexone—alcohol dependence	0.00113	0.00778	CcSEcCtD
Regorafenib—FLT4—adrenal cortex—alcohol dependence	0.00111	0.00755	CbGeAlD
Regorafenib—Infestation NOS—Naltrexone—alcohol dependence	0.00111	0.00766	CcSEcCtD
Regorafenib—Infestation—Naltrexone—alcohol dependence	0.00111	0.00766	CcSEcCtD
Regorafenib—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00109	0.00755	CcSEcCtD
Regorafenib—Asthenia—Disulfiram—alcohol dependence	0.00109	0.00752	CcSEcCtD
Regorafenib—DDR2—testis—alcohol dependence	0.00109	0.0074	CbGeAlD
Regorafenib—Myocardial infarction—Naltrexone—alcohol dependence	0.00109	0.00751	CcSEcCtD
Regorafenib—DDR2—nervous system—alcohol dependence	0.00107	0.00726	CbGeAlD
Regorafenib—Haemoglobin—Acamprosate—alcohol dependence	0.00106	0.00731	CcSEcCtD
Regorafenib—Haemorrhage—Acamprosate—alcohol dependence	0.00105	0.00727	CcSEcCtD
Regorafenib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00105	0.00725	CcSEcCtD
Regorafenib—FGFR2—brainstem—alcohol dependence	0.00104	0.00708	CbGeAlD
Regorafenib—MAPK11—testis—alcohol dependence	0.00103	0.00701	CbGeAlD
Regorafenib—Gastroenteritis—Citalopram—alcohol dependence	0.00103	0.00711	CcSEcCtD
Regorafenib—DDR2—liver—alcohol dependence	0.00103	0.00699	CbGeAlD
Regorafenib—DDR2—central nervous system—alcohol dependence	0.00103	0.00699	CbGeAlD
Regorafenib—FLT4—cardiovascular system—alcohol dependence	0.00101	0.00689	CbGeAlD
Regorafenib—MAPK11—nervous system—alcohol dependence	0.00101	0.00688	CbGeAlD
Regorafenib—FGFR2—forebrain—alcohol dependence	0.001	0.00684	CbGeAlD
Regorafenib—DDR2—cerebellum—alcohol dependence	0.001	0.00683	CbGeAlD
Regorafenib—Connective tissue disorder—Naltrexone—alcohol dependence	0.000978	0.00676	CcSEcCtD
Regorafenib—MAPK11—central nervous system—alcohol dependence	0.000974	0.00663	CbGeAlD
Regorafenib—RAF1—brainstem—alcohol dependence	0.000959	0.00653	CbGeAlD
Regorafenib—Rash—Disulfiram—alcohol dependence	0.000957	0.00661	CcSEcCtD
Regorafenib—MAPK11—cerebellum—alcohol dependence	0.000952	0.00648	CbGeAlD
Regorafenib—Headache—Disulfiram—alcohol dependence	0.000951	0.00657	CcSEcCtD
Regorafenib—Alopecia—Acamprosate—alcohol dependence	0.00093	0.00643	CcSEcCtD
Regorafenib—BRAF—blood—alcohol dependence	0.000929	0.00632	CbGeAlD
Regorafenib—RAF1—forebrain—alcohol dependence	0.000926	0.0063	CbGeAlD
Regorafenib—Cardiac disorder—Naltrexone—alcohol dependence	0.000924	0.00639	CcSEcCtD
Regorafenib—BRAF—midbrain—alcohol dependence	0.000917	0.00624	CbGeAlD
Regorafenib—Malnutrition—Acamprosate—alcohol dependence	0.000916	0.00633	CcSEcCtD
Regorafenib—Hyponatraemia—Citalopram—alcohol dependence	0.000915	0.00633	CcSEcCtD
Regorafenib—EPHA2—adrenal cortex—alcohol dependence	0.000915	0.00622	CbGeAlD
Regorafenib—Angiopathy—Naltrexone—alcohol dependence	0.000903	0.00624	CcSEcCtD
Regorafenib—Mediastinal disorder—Naltrexone—alcohol dependence	0.000897	0.0062	CcSEcCtD
Regorafenib—TEK—adrenal cortex—alcohol dependence	0.000892	0.00607	CbGeAlD
Regorafenib—EPHX2—blood—alcohol dependence	0.000888	0.00604	CbGeAlD
Regorafenib—Alopecia—Naltrexone—alcohol dependence	0.00088	0.00608	CcSEcCtD
Regorafenib—PDGFRA—forebrain—alcohol dependence	0.000872	0.00594	CbGeAlD
Regorafenib—Malnutrition—Naltrexone—alcohol dependence	0.000867	0.00599	CcSEcCtD
Regorafenib—FLT1—adrenal cortex—alcohol dependence	0.000863	0.00587	CbGeAlD
Regorafenib—Tremor—Acamprosate—alcohol dependence	0.000858	0.00593	CcSEcCtD
Regorafenib—RAF1—adrenal cortex—alcohol dependence	0.000858	0.00584	CbGeAlD
Regorafenib—UGT1A9—digestive system—alcohol dependence	0.000852	0.0058	CbGeAlD
Regorafenib—FGFR2—cardiovascular system—alcohol dependence	0.000849	0.00578	CbGeAlD
Regorafenib—Anaemia—Acamprosate—alcohol dependence	0.000847	0.00585	CcSEcCtD
Regorafenib—Dry skin—Citalopram—alcohol dependence	0.000836	0.00578	CcSEcCtD
Regorafenib—EPHA2—cardiovascular system—alcohol dependence	0.000835	0.00568	CbGeAlD
Regorafenib—Hypokalaemia—Citalopram—alcohol dependence	0.00083	0.00573	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000821	0.00567	CcSEcCtD
Regorafenib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000821	0.00567	CcSEcCtD
Regorafenib—Leukopenia—Acamprosate—alcohol dependence	0.00082	0.00567	CcSEcCtD
Regorafenib—DDR2—brain—alcohol dependence	0.000816	0.00555	CbGeAlD
Regorafenib—TEK—cardiovascular system—alcohol dependence	0.000814	0.00554	CbGeAlD
Regorafenib—Tremor—Naltrexone—alcohol dependence	0.000812	0.00561	CcSEcCtD
Regorafenib—EPHA2—pancreas—alcohol dependence	0.000811	0.00552	CbGeAlD
Regorafenib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000804	0.00556	CcSEcCtD
Regorafenib—FLT4—blood—alcohol dependence	0.000801	0.00545	CbGeAlD
Regorafenib—TEK—pancreas—alcohol dependence	0.000791	0.00539	CbGeAlD
Regorafenib—Hypertension—Acamprosate—alcohol dependence	0.000791	0.00547	CcSEcCtD
Regorafenib—FLT1—cardiovascular system—alcohol dependence	0.000787	0.00536	CbGeAlD
Regorafenib—KDR—forebrain—alcohol dependence	0.000787	0.00536	CbGeAlD
Regorafenib—RAF1—cardiovascular system—alcohol dependence	0.000783	0.00533	CbGeAlD
Regorafenib—FGFR1—midbrain—alcohol dependence	0.00078	0.00531	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000774	0.00535	CcSEcCtD
Regorafenib—MAPK11—brain—alcohol dependence	0.000773	0.00526	CbGeAlD
Regorafenib—BRAF—testis—alcohol dependence	0.000768	0.00523	CbGeAlD
Regorafenib—FLT1—pancreas—alcohol dependence	0.000765	0.00521	CbGeAlD
Regorafenib—Dry mouth—Acamprosate—alcohol dependence	0.000763	0.00527	CcSEcCtD
Regorafenib—RAF1—pancreas—alcohol dependence	0.000761	0.00518	CbGeAlD
Regorafenib—Hypertension—Naltrexone—alcohol dependence	0.000748	0.00517	CcSEcCtD
Regorafenib—Infection—Acamprosate—alcohol dependence	0.000743	0.00513	CcSEcCtD
Regorafenib—RET—digestive system—alcohol dependence	0.000742	0.00505	CbGeAlD
Regorafenib—PDGFRA—cardiovascular system—alcohol dependence	0.000738	0.00502	CbGeAlD
Regorafenib—EPHX2—testis—alcohol dependence	0.000734	0.005	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000733	0.00506	CcSEcCtD
Regorafenib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000732	0.00506	CcSEcCtD
Regorafenib—KDR—adrenal cortex—alcohol dependence	0.000729	0.00496	CbGeAlD
Regorafenib—BRAF—liver—alcohol dependence	0.000726	0.00494	CbGeAlD
Regorafenib—Skin disorder—Acamprosate—alcohol dependence	0.000726	0.00502	CcSEcCtD
Regorafenib—KIT—brainstem—alcohol dependence	0.000723	0.00492	CbGeAlD
Regorafenib—Dry mouth—Naltrexone—alcohol dependence	0.000721	0.00499	CcSEcCtD
Regorafenib—FLT1—gonad—alcohol dependence	0.000714	0.00486	CbGeAlD
Regorafenib—Weight decreased—Citalopram—alcohol dependence	0.000713	0.00493	CcSEcCtD
Regorafenib—RAF1—gonad—alcohol dependence	0.00071	0.00483	CbGeAlD
Regorafenib—BRAF—cerebellum—alcohol dependence	0.00071	0.00483	CbGeAlD
Regorafenib—RET—blood—alcohol dependence	0.000707	0.00481	CbGeAlD
Regorafenib—FGFR2—digestive system—alcohol dependence	0.000705	0.0048	CbGeAlD
Regorafenib—UGT1A9—endocrine gland—alcohol dependence	0.000704	0.00479	CbGeAlD
Regorafenib—Infection—Naltrexone—alcohol dependence	0.000703	0.00486	CcSEcCtD
Regorafenib—Infestation NOS—Citalopram—alcohol dependence	0.000703	0.00486	CcSEcCtD
Regorafenib—Infestation—Citalopram—alcohol dependence	0.000703	0.00486	CcSEcCtD
Regorafenib—RET—midbrain—alcohol dependence	0.000698	0.00475	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000697	0.00481	CcSEcCtD
Regorafenib—FLT4—endocrine gland—alcohol dependence	0.000694	0.00473	CbGeAlD
Regorafenib—EPHX2—liver—alcohol dependence	0.000694	0.00472	CbGeAlD
Regorafenib—Nervous system disorder—Naltrexone—alcohol dependence	0.000694	0.00479	CcSEcCtD
Regorafenib—EPHA2—digestive system—alcohol dependence	0.000693	0.00472	CbGeAlD
Regorafenib—Acute coronary syndrome—Citalopram—alcohol dependence	0.000693	0.00479	CcSEcCtD
Regorafenib—Myocardial infarction—Citalopram—alcohol dependence	0.000689	0.00476	CcSEcCtD
Regorafenib—Skin disorder—Naltrexone—alcohol dependence	0.000687	0.00475	CcSEcCtD
Regorafenib—Stomatitis—Citalopram—alcohol dependence	0.000685	0.00473	CcSEcCtD
Regorafenib—EPHX2—cerebellum—alcohol dependence	0.000678	0.00462	CbGeAlD
Regorafenib—FGFR2—blood—alcohol dependence	0.000672	0.00457	CbGeAlD
Regorafenib—PDGFRA—gonad—alcohol dependence	0.000669	0.00456	CbGeAlD
Regorafenib—KDR—cardiovascular system—alcohol dependence	0.000665	0.00453	CbGeAlD
Regorafenib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000664	0.00459	CcSEcCtD
Regorafenib—FLT4—testis—alcohol dependence	0.000662	0.00451	CbGeAlD
Regorafenib—EPHA2—blood—alcohol dependence	0.00066	0.00449	CbGeAlD
Regorafenib—FLT1—digestive system—alcohol dependence	0.000653	0.00445	CbGeAlD
Regorafenib—FGFR1—testis—alcohol dependence	0.000653	0.00445	CbGeAlD
Regorafenib—Decreased appetite—Acamprosate—alcohol dependence	0.00065	0.00449	CcSEcCtD
Regorafenib—RAF1—digestive system—alcohol dependence	0.00065	0.00442	CbGeAlD
Regorafenib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000645	0.00446	CcSEcCtD
Regorafenib—TEK—blood—alcohol dependence	0.000644	0.00438	CbGeAlD
Regorafenib—Pain—Acamprosate—alcohol dependence	0.000639	0.00442	CcSEcCtD
Regorafenib—TEK—midbrain—alcohol dependence	0.000636	0.00433	CbGeAlD
Regorafenib—UGT1A9—liver—alcohol dependence	0.000635	0.00432	CbGeAlD
Regorafenib—Haemoglobin—Citalopram—alcohol dependence	0.000634	0.00438	CcSEcCtD
Regorafenib—PDGFRB—adrenal cortex—alcohol dependence	0.000631	0.0043	CbGeAlD
Regorafenib—Haemorrhage—Citalopram—alcohol dependence	0.000631	0.00436	CcSEcCtD
Regorafenib—ABL1—brainstem—alcohol dependence	0.000629	0.00428	CbGeAlD
Regorafenib—FLT4—liver—alcohol dependence	0.000626	0.00426	CbGeAlD
Regorafenib—Urinary tract disorder—Citalopram—alcohol dependence	0.000623	0.0043	CcSEcCtD
Regorafenib—FLT1—blood—alcohol dependence	0.000623	0.00424	CbGeAlD
Regorafenib—Connective tissue disorder—Citalopram—alcohol dependence	0.00062	0.00428	CcSEcCtD
Regorafenib—RAF1—blood—alcohol dependence	0.000619	0.00421	CbGeAlD
Regorafenib—Urethral disorder—Citalopram—alcohol dependence	0.000618	0.00427	CcSEcCtD
Regorafenib—FGFR1—liver—alcohol dependence	0.000618	0.0042	CbGeAlD
Regorafenib—Decreased appetite—Naltrexone—alcohol dependence	0.000615	0.00425	CcSEcCtD
Regorafenib—FLT1—midbrain—alcohol dependence	0.000615	0.00418	CbGeAlD
Regorafenib—RET—endocrine gland—alcohol dependence	0.000613	0.00417	CbGeAlD
Regorafenib—PDGFRA—digestive system—alcohol dependence	0.000612	0.00417	CbGeAlD
Regorafenib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000611	0.00422	CcSEcCtD
Regorafenib—RAF1—midbrain—alcohol dependence	0.000611	0.00416	CbGeAlD
Regorafenib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000611	0.00422	CcSEcCtD
Regorafenib—Fatigue—Naltrexone—alcohol dependence	0.00061	0.00421	CcSEcCtD
Regorafenib—Pain—Naltrexone—alcohol dependence	0.000605	0.00418	CcSEcCtD
Regorafenib—FGFR1—cerebellum—alcohol dependence	0.000603	0.00411	CbGeAlD
Regorafenib—Erythema multiforme—Citalopram—alcohol dependence	0.000596	0.00412	CcSEcCtD
Regorafenib—Body temperature increased—Acamprosate—alcohol dependence	0.000591	0.00408	CcSEcCtD
Regorafenib—Abdominal pain—Acamprosate—alcohol dependence	0.000591	0.00408	CcSEcCtD
Regorafenib—KIT—cardiovascular system—alcohol dependence	0.00059	0.00401	CbGeAlD
Regorafenib—Cardiac disorder—Citalopram—alcohol dependence	0.000585	0.00405	CcSEcCtD
Regorafenib—RET—testis—alcohol dependence	0.000585	0.00398	CbGeAlD
Regorafenib—UGT1A1—digestive system—alcohol dependence	0.000584	0.00398	CbGeAlD
Regorafenib—PDGFRA—blood—alcohol dependence	0.000583	0.00397	CbGeAlD
Regorafenib—FGFR2—endocrine gland—alcohol dependence	0.000583	0.00396	CbGeAlD
Regorafenib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000578	0.004	CcSEcCtD
Regorafenib—BRAF—brain—alcohol dependence	0.000576	0.00392	CbGeAlD
Regorafenib—PDGFRB—cardiovascular system—alcohol dependence	0.000576	0.00392	CbGeAlD
Regorafenib—RET—nervous system—alcohol dependence	0.000574	0.00391	CbGeAlD
Regorafenib—KIT—pancreas—alcohol dependence	0.000573	0.0039	CbGeAlD
Regorafenib—EPHA2—endocrine gland—alcohol dependence	0.000572	0.0039	CbGeAlD
Regorafenib—Angiopathy—Citalopram—alcohol dependence	0.000572	0.00395	CcSEcCtD
Regorafenib—Mediastinal disorder—Citalopram—alcohol dependence	0.000568	0.00393	CcSEcCtD
Regorafenib—ABL1—adrenal cortex—alcohol dependence	0.000563	0.00383	CbGeAlD
Regorafenib—PDGFRB—pancreas—alcohol dependence	0.00056	0.00381	CbGeAlD
Regorafenib—Body temperature increased—Naltrexone—alcohol dependence	0.000559	0.00386	CcSEcCtD
Regorafenib—Abdominal pain—Naltrexone—alcohol dependence	0.000559	0.00386	CcSEcCtD
Regorafenib—TEK—endocrine gland—alcohol dependence	0.000558	0.0038	CbGeAlD
Regorafenib—Alopecia—Citalopram—alcohol dependence	0.000557	0.00385	CcSEcCtD
Regorafenib—UGT1A1—blood—alcohol dependence	0.000556	0.00379	CbGeAlD
Regorafenib—FGFR2—testis—alcohol dependence	0.000556	0.00378	CbGeAlD
Regorafenib—RET—central nervous system—alcohol dependence	0.000552	0.00376	CbGeAlD
Regorafenib—KDR—digestive system—alcohol dependence	0.000552	0.00376	CbGeAlD
Regorafenib—EPHX2—brain—alcohol dependence	0.000551	0.00375	CbGeAlD
Regorafenib—Malnutrition—Citalopram—alcohol dependence	0.000549	0.00379	CcSEcCtD
Regorafenib—EPHA2—testis—alcohol dependence	0.000546	0.00372	CbGeAlD
Regorafenib—FGFR2—nervous system—alcohol dependence	0.000545	0.00371	CbGeAlD
Regorafenib—RET—cerebellum—alcohol dependence	0.00054	0.00368	CbGeAlD
Regorafenib—FLT1—endocrine gland—alcohol dependence	0.00054	0.00367	CbGeAlD
Regorafenib—RAF1—endocrine gland—alcohol dependence	0.000537	0.00365	CbGeAlD
Regorafenib—Asthenia—Acamprosate—alcohol dependence	0.000536	0.00371	CcSEcCtD
Regorafenib—EPHA2—nervous system—alcohol dependence	0.000536	0.00365	CbGeAlD
Regorafenib—KIT—gonad—alcohol dependence	0.000535	0.00364	CbGeAlD
Regorafenib—TEK—testis—alcohol dependence	0.000533	0.00362	CbGeAlD
Regorafenib—KDR—blood—alcohol dependence	0.000526	0.00358	CbGeAlD
Regorafenib—FGFR2—liver—alcohol dependence	0.000525	0.00357	CbGeAlD
Regorafenib—FGFR2—central nervous system—alcohol dependence	0.000525	0.00357	CbGeAlD
Regorafenib—PDGFRB—gonad—alcohol dependence	0.000523	0.00356	CbGeAlD
Regorafenib—TEK—nervous system—alcohol dependence	0.000523	0.00356	CbGeAlD
Regorafenib—KDR—midbrain—alcohol dependence	0.00052	0.00354	CbGeAlD
Regorafenib—EPHA2—liver—alcohol dependence	0.000516	0.00351	CbGeAlD
Regorafenib—EPHA2—central nervous system—alcohol dependence	0.000516	0.00351	CbGeAlD
Regorafenib—FLT1—testis—alcohol dependence	0.000515	0.0035	CbGeAlD
Regorafenib—Tremor—Citalopram—alcohol dependence	0.000514	0.00356	CcSEcCtD
Regorafenib—ABL1—cardiovascular system—alcohol dependence	0.000513	0.00349	CbGeAlD
Regorafenib—FGFR2—cerebellum—alcohol dependence	0.000513	0.00349	CbGeAlD
Regorafenib—RAF1—testis—alcohol dependence	0.000512	0.00348	CbGeAlD
Regorafenib—Diarrhoea—Acamprosate—alcohol dependence	0.000511	0.00353	CcSEcCtD
Regorafenib—Anaemia—Citalopram—alcohol dependence	0.000507	0.00351	CcSEcCtD
Regorafenib—Asthenia—Naltrexone—alcohol dependence	0.000507	0.00351	CcSEcCtD
Regorafenib—PDGFRA—endocrine gland—alcohol dependence	0.000506	0.00344	CbGeAlD
Regorafenib—FLT1—nervous system—alcohol dependence	0.000505	0.00344	CbGeAlD
Regorafenib—TEK—liver—alcohol dependence	0.000504	0.00343	CbGeAlD
Regorafenib—TEK—central nervous system—alcohol dependence	0.000503	0.00343	CbGeAlD
Regorafenib—RAF1—nervous system—alcohol dependence	0.000502	0.00342	CbGeAlD
Regorafenib—ABL1—pancreas—alcohol dependence	0.000499	0.0034	CbGeAlD
Regorafenib—FLT4—brain—alcohol dependence	0.000497	0.00338	CbGeAlD
Regorafenib—TEK—cerebellum—alcohol dependence	0.000492	0.00335	CbGeAlD
Regorafenib—Leukopenia—Citalopram—alcohol dependence	0.000491	0.0034	CcSEcCtD
Regorafenib—FGFR1—brain—alcohol dependence	0.00049	0.00334	CbGeAlD
Regorafenib—KIT—digestive system—alcohol dependence	0.00049	0.00333	CbGeAlD
Regorafenib—FLT1—liver—alcohol dependence	0.000487	0.00331	CbGeAlD
Regorafenib—FLT1—central nervous system—alcohol dependence	0.000487	0.00331	CbGeAlD
Regorafenib—RAF1—liver—alcohol dependence	0.000484	0.00329	CbGeAlD
Regorafenib—Diarrhoea—Naltrexone—alcohol dependence	0.000484	0.00334	CcSEcCtD
Regorafenib—RAF1—central nervous system—alcohol dependence	0.000484	0.00329	CbGeAlD
Regorafenib—UGT1A1—endocrine gland—alcohol dependence	0.000483	0.00329	CbGeAlD
Regorafenib—PDGFRA—testis—alcohol dependence	0.000483	0.00328	CbGeAlD
Regorafenib—PDGFRB—digestive system—alcohol dependence	0.000478	0.00325	CbGeAlD
Regorafenib—FLT1—cerebellum—alcohol dependence	0.000476	0.00324	CbGeAlD
Regorafenib—Vomiting—Acamprosate—alcohol dependence	0.000475	0.00328	CcSEcCtD
Regorafenib—Hypertension—Citalopram—alcohol dependence	0.000474	0.00328	CcSEcCtD
Regorafenib—PDGFRA—nervous system—alcohol dependence	0.000474	0.00322	CbGeAlD
Regorafenib—RAF1—cerebellum—alcohol dependence	0.000473	0.00322	CbGeAlD
Regorafenib—Rash—Acamprosate—alcohol dependence	0.000471	0.00326	CcSEcCtD
Regorafenib—Dermatitis—Acamprosate—alcohol dependence	0.000471	0.00325	CcSEcCtD
Regorafenib—Headache—Acamprosate—alcohol dependence	0.000468	0.00324	CcSEcCtD
Regorafenib—KIT—blood—alcohol dependence	0.000466	0.00317	CbGeAlD
Regorafenib—ABL1—gonad—alcohol dependence	0.000466	0.00317	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000464	0.00321	CcSEcCtD
Regorafenib—KIT—midbrain—alcohol dependence	0.000461	0.00313	CbGeAlD
Regorafenib—Dry mouth—Citalopram—alcohol dependence	0.000457	0.00316	CcSEcCtD
Regorafenib—KDR—endocrine gland—alcohol dependence	0.000456	0.00311	CbGeAlD
Regorafenib—PDGFRA—liver—alcohol dependence	0.000456	0.0031	CbGeAlD
Regorafenib—PDGFRA—central nervous system—alcohol dependence	0.000456	0.0031	CbGeAlD
Regorafenib—PDGFRB—blood—alcohol dependence	0.000455	0.0031	CbGeAlD
Regorafenib—PDGFRB—midbrain—alcohol dependence	0.00045	0.00306	CbGeAlD
Regorafenib—Vomiting—Naltrexone—alcohol dependence	0.00045	0.00311	CcSEcCtD
Regorafenib—Rash—Naltrexone—alcohol dependence	0.000446	0.00308	CcSEcCtD
Regorafenib—PDGFRA—cerebellum—alcohol dependence	0.000446	0.00303	CbGeAlD
Regorafenib—Dermatitis—Naltrexone—alcohol dependence	0.000445	0.00308	CcSEcCtD
Regorafenib—Infection—Citalopram—alcohol dependence	0.000445	0.00308	CcSEcCtD
Regorafenib—Nausea—Acamprosate—alcohol dependence	0.000444	0.00307	CcSEcCtD
Regorafenib—Headache—Naltrexone—alcohol dependence	0.000443	0.00306	CcSEcCtD
Regorafenib—Nervous system disorder—Citalopram—alcohol dependence	0.000439	0.00304	CcSEcCtD
Regorafenib—Thrombocytopenia—Citalopram—alcohol dependence	0.000439	0.00303	CcSEcCtD
Regorafenib—RET—brain—alcohol dependence	0.000439	0.00299	CbGeAlD
Regorafenib—KDR—testis—alcohol dependence	0.000435	0.00296	CbGeAlD
Regorafenib—Skin disorder—Citalopram—alcohol dependence	0.000435	0.00301	CcSEcCtD
Regorafenib—UGT1A1—liver—alcohol dependence	0.000435	0.00296	CbGeAlD
Regorafenib—KDR—nervous system—alcohol dependence	0.000427	0.00291	CbGeAlD
Regorafenib—ABL1—digestive system—alcohol dependence	0.000426	0.0029	CbGeAlD
Regorafenib—Nausea—Naltrexone—alcohol dependence	0.00042	0.0029	CcSEcCtD
Regorafenib—FGFR2—brain—alcohol dependence	0.000417	0.00284	CbGeAlD
Regorafenib—KDR—liver—alcohol dependence	0.000412	0.0028	CbGeAlD
Regorafenib—KDR—central nervous system—alcohol dependence	0.000411	0.0028	CbGeAlD
Regorafenib—EPHA2—brain—alcohol dependence	0.00041	0.00279	CbGeAlD
Regorafenib—ABL1—blood—alcohol dependence	0.000406	0.00276	CbGeAlD
Regorafenib—KIT—endocrine gland—alcohol dependence	0.000404	0.00275	CbGeAlD
Regorafenib—KDR—cerebellum—alcohol dependence	0.000402	0.00274	CbGeAlD
Regorafenib—ABL1—midbrain—alcohol dependence	0.000401	0.00273	CbGeAlD
Regorafenib—TEK—brain—alcohol dependence	0.0004	0.00272	CbGeAlD
Regorafenib—PDGFRB—endocrine gland—alcohol dependence	0.000395	0.00269	CbGeAlD
Regorafenib—Decreased appetite—Citalopram—alcohol dependence	0.00039	0.00269	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000387	0.00267	CcSEcCtD
Regorafenib—Fatigue—Citalopram—alcohol dependence	0.000386	0.00267	CcSEcCtD
Regorafenib—FLT1—brain—alcohol dependence	0.000386	0.00263	CbGeAlD
Regorafenib—KIT—testis—alcohol dependence	0.000386	0.00263	CbGeAlD
Regorafenib—RAF1—brain—alcohol dependence	0.000384	0.00261	CbGeAlD
Regorafenib—Pain—Citalopram—alcohol dependence	0.000383	0.00265	CcSEcCtD
Regorafenib—KIT—nervous system—alcohol dependence	0.000379	0.00258	CbGeAlD
Regorafenib—PDGFRB—testis—alcohol dependence	0.000377	0.00256	CbGeAlD
Regorafenib—PDGFRB—nervous system—alcohol dependence	0.00037	0.00252	CbGeAlD
Regorafenib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000366	0.00253	CcSEcCtD
Regorafenib—KIT—liver—alcohol dependence	0.000365	0.00248	CbGeAlD
Regorafenib—KIT—central nervous system—alcohol dependence	0.000364	0.00248	CbGeAlD
Regorafenib—PDGFRA—brain—alcohol dependence	0.000362	0.00246	CbGeAlD
Regorafenib—KIT—cerebellum—alcohol dependence	0.000356	0.00242	CbGeAlD
Regorafenib—PDGFRB—liver—alcohol dependence	0.000356	0.00242	CbGeAlD
Regorafenib—PDGFRB—central nervous system—alcohol dependence	0.000356	0.00242	CbGeAlD
Regorafenib—ABCG2—adrenal cortex—alcohol dependence	0.000355	0.00241	CbGeAlD
Regorafenib—Body temperature increased—Citalopram—alcohol dependence	0.000354	0.00245	CcSEcCtD
Regorafenib—Abdominal pain—Citalopram—alcohol dependence	0.000354	0.00245	CcSEcCtD
Regorafenib—ABL1—endocrine gland—alcohol dependence	0.000352	0.0024	CbGeAlD
Regorafenib—PDGFRB—cerebellum—alcohol dependence	0.000348	0.00237	CbGeAlD
Regorafenib—ABL1—testis—alcohol dependence	0.000336	0.00229	CbGeAlD
Regorafenib—ABL1—nervous system—alcohol dependence	0.00033	0.00224	CbGeAlD
Regorafenib—CYP2B6—adrenal cortex—alcohol dependence	0.000327	0.00223	CbGeAlD
Regorafenib—KDR—brain—alcohol dependence	0.000327	0.00222	CbGeAlD
Regorafenib—Asthenia—Citalopram—alcohol dependence	0.000321	0.00222	CcSEcCtD
Regorafenib—ABL1—liver—alcohol dependence	0.000317	0.00216	CbGeAlD
Regorafenib—ABL1—central nervous system—alcohol dependence	0.000317	0.00216	CbGeAlD
Regorafenib—CYP2C19—digestive system—alcohol dependence	0.000317	0.00216	CbGeAlD
Regorafenib—ABL1—cerebellum—alcohol dependence	0.00031	0.00211	CbGeAlD
Regorafenib—Diarrhoea—Citalopram—alcohol dependence	0.000307	0.00212	CcSEcCtD
Regorafenib—CYP2C19—blood—alcohol dependence	0.000302	0.00205	CbGeAlD
Regorafenib—CYP2B6—cardiovascular system—alcohol dependence	0.000299	0.00203	CbGeAlD
Regorafenib—CYP2C9—cardiovascular system—alcohol dependence	0.000296	0.00201	CbGeAlD
Regorafenib—KIT—brain—alcohol dependence	0.000289	0.00197	CbGeAlD
Regorafenib—Vomiting—Citalopram—alcohol dependence	0.000285	0.00197	CcSEcCtD
Regorafenib—PDGFRB—brain—alcohol dependence	0.000283	0.00192	CbGeAlD
Regorafenib—Rash—Citalopram—alcohol dependence	0.000283	0.00195	CcSEcCtD
Regorafenib—Dermatitis—Citalopram—alcohol dependence	0.000282	0.00195	CcSEcCtD
Regorafenib—Headache—Citalopram—alcohol dependence	0.000281	0.00194	CcSEcCtD
Regorafenib—CYP2B6—gonad—alcohol dependence	0.000271	0.00184	CbGeAlD
Regorafenib—Nausea—Citalopram—alcohol dependence	0.000266	0.00184	CcSEcCtD
Regorafenib—CYP2C8—blood—alcohol dependence	0.000263	0.00179	CbGeAlD
Regorafenib—CYP2C19—endocrine gland—alcohol dependence	0.000262	0.00178	CbGeAlD
Regorafenib—ABCG2—blood—alcohol dependence	0.000256	0.00174	CbGeAlD
Regorafenib—ABCG2—midbrain—alcohol dependence	0.000253	0.00172	CbGeAlD
Regorafenib—ABL1—brain—alcohol dependence	0.000252	0.00171	CbGeAlD
Regorafenib—CYP2B6—digestive system—alcohol dependence	0.000248	0.00169	CbGeAlD
Regorafenib—CYP2C9—digestive system—alcohol dependence	0.000245	0.00167	CbGeAlD
Regorafenib—CYP2B6—blood—alcohol dependence	0.000236	0.00161	CbGeAlD
Regorafenib—CYP2C19—liver—alcohol dependence	0.000236	0.00161	CbGeAlD
Regorafenib—CYP2C9—blood—alcohol dependence	0.000234	0.00159	CbGeAlD
Regorafenib—CYP2C8—endocrine gland—alcohol dependence	0.000228	0.00155	CbGeAlD
Regorafenib—CYP2C8—testis—alcohol dependence	0.000218	0.00148	CbGeAlD
Regorafenib—ABCG2—testis—alcohol dependence	0.000212	0.00144	CbGeAlD
Regorafenib—CYP2C8—liver—alcohol dependence	0.000206	0.0014	CbGeAlD
Regorafenib—CYP2B6—endocrine gland—alcohol dependence	0.000205	0.00139	CbGeAlD
Regorafenib—CYP2C9—endocrine gland—alcohol dependence	0.000203	0.00138	CbGeAlD
Regorafenib—ABCG2—liver—alcohol dependence	0.0002	0.00136	CbGeAlD
Regorafenib—ABCG2—cerebellum—alcohol dependence	0.000196	0.00133	CbGeAlD
Regorafenib—CYP2B6—testis—alcohol dependence	0.000195	0.00133	CbGeAlD
Regorafenib—CYP2B6—nervous system—alcohol dependence	0.000192	0.0013	CbGeAlD
Regorafenib—ABCB1—forebrain—alcohol dependence	0.000189	0.00128	CbGeAlD
Regorafenib—CYP3A4—digestive system—alcohol dependence	0.000187	0.00127	CbGeAlD
Regorafenib—CYP2B6—liver—alcohol dependence	0.000185	0.00126	CbGeAlD
Regorafenib—CYP2B6—central nervous system—alcohol dependence	0.000185	0.00126	CbGeAlD
Regorafenib—CYP2C9—liver—alcohol dependence	0.000183	0.00124	CbGeAlD
Regorafenib—CYP3A4—blood—alcohol dependence	0.000178	0.00121	CbGeAlD
Regorafenib—ABCB1—adrenal cortex—alcohol dependence	0.000175	0.00119	CbGeAlD
Regorafenib—CYP2C8—brain—alcohol dependence	0.000163	0.00111	CbGeAlD
Regorafenib—ABCB1—cardiovascular system—alcohol dependence	0.00016	0.00109	CbGeAlD
Regorafenib—ABCG2—brain—alcohol dependence	0.000159	0.00108	CbGeAlD
Regorafenib—ABCB1—pancreas—alcohol dependence	0.000155	0.00106	CbGeAlD
Regorafenib—CYP3A4—endocrine gland—alcohol dependence	0.000155	0.00105	CbGeAlD
Regorafenib—CYP2B6—brain—alcohol dependence	0.000147	0.000997	CbGeAlD
Regorafenib—ABCB1—gonad—alcohol dependence	0.000145	0.000986	CbGeAlD
Regorafenib—CYP3A4—nervous system—alcohol dependence	0.000145	0.000985	CbGeAlD
Regorafenib—CYP3A4—liver—alcohol dependence	0.000139	0.000949	CbGeAlD
Regorafenib—CYP3A4—central nervous system—alcohol dependence	0.000139	0.000949	CbGeAlD
Regorafenib—ABCB1—digestive system—alcohol dependence	0.000133	0.000902	CbGeAlD
Regorafenib—ABCB1—blood—alcohol dependence	0.000126	0.000859	CbGeAlD
Regorafenib—ABCB1—midbrain—alcohol dependence	0.000125	0.000848	CbGeAlD
Regorafenib—ABCB1—endocrine gland—alcohol dependence	0.000109	0.000745	CbGeAlD
Regorafenib—ABCB1—testis—alcohol dependence	0.000104	0.000711	CbGeAlD
Regorafenib—ABCB1—nervous system—alcohol dependence	0.000102	0.000697	CbGeAlD
Regorafenib—ABCB1—liver—alcohol dependence	9.87e-05	0.000672	CbGeAlD
Regorafenib—ABCB1—central nervous system—alcohol dependence	9.87e-05	0.000672	CbGeAlD
Regorafenib—ABCB1—cerebellum—alcohol dependence	9.64e-05	0.000656	CbGeAlD
Regorafenib—ABCB1—brain—alcohol dependence	7.83e-05	0.000533	CbGeAlD
Regorafenib—CYP2B6—Metabolism—ADH7—alcohol dependence	2.94e-05	0.00023	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR1B—alcohol dependence	2.94e-05	0.00023	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CRH—alcohol dependence	2.94e-05	0.00023	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADH4—alcohol dependence	2.93e-05	0.000229	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ALDH2—alcohol dependence	2.92e-05	0.000229	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ALDH2—alcohol dependence	2.92e-05	0.000229	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MAOB—alcohol dependence	2.91e-05	0.000228	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CRHR1—alcohol dependence	2.91e-05	0.000228	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—WASF2—alcohol dependence	2.91e-05	0.000228	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NPY—alcohol dependence	2.89e-05	0.000226	CbGpPWpGaD
Regorafenib—RAF1—Disease—GOT2—alcohol dependence	2.88e-05	0.000226	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NPY—alcohol dependence	2.88e-05	0.000226	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DRD4—alcohol dependence	2.85e-05	0.000223	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—OPRM1—alcohol dependence	2.82e-05	0.000221	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DRD4—alcohol dependence	2.82e-05	0.000221	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GGT2—alcohol dependence	2.82e-05	0.000221	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.81e-05	0.00022	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—EP300—alcohol dependence	2.8e-05	0.00022	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADH1A—alcohol dependence	2.8e-05	0.000219	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—WASF1—alcohol dependence	2.79e-05	0.000219	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—GOT1—alcohol dependence	2.79e-05	0.000219	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR1B—alcohol dependence	2.79e-05	0.000218	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CRH—alcohol dependence	2.79e-05	0.000218	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR1B—alcohol dependence	2.78e-05	0.000218	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CRH—alcohol dependence	2.78e-05	0.000218	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AVP—alcohol dependence	2.75e-05	0.000215	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CHRM2—alcohol dependence	2.74e-05	0.000215	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CNR1—alcohol dependence	2.72e-05	0.000213	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CNR1—alcohol dependence	2.69e-05	0.000211	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR7—alcohol dependence	2.65e-05	0.000208	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—DRD2—alcohol dependence	2.65e-05	0.000208	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR7—alcohol dependence	2.63e-05	0.000206	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—DRD2—alcohol dependence	2.63e-05	0.000206	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DRD4—alcohol dependence	2.61e-05	0.000205	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—EP300—alcohol dependence	2.61e-05	0.000205	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADH4—alcohol dependence	2.61e-05	0.000205	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NPY—alcohol dependence	2.6e-05	0.000203	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AVP—alcohol dependence	2.6e-05	0.000203	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—POMC—alcohol dependence	2.59e-05	0.000203	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AVP—alcohol dependence	2.59e-05	0.000203	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ADH1B—alcohol dependence	2.58e-05	0.000202	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DRD4—alcohol dependence	2.57e-05	0.000201	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADH4—alcohol dependence	2.55e-05	0.0002	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.53e-05	0.000198	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—EP300—alcohol dependence	2.53e-05	0.000198	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—OPRM1—alcohol dependence	2.52e-05	0.000197	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR1B—alcohol dependence	2.51e-05	0.000196	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CRH—alcohol dependence	2.51e-05	0.000196	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CNR1—alcohol dependence	2.5e-05	0.000196	CbGpPWpGaD
Regorafenib—RAF1—Disease—GOT1—alcohol dependence	2.49e-05	0.000195	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADH7—alcohol dependence	2.49e-05	0.000195	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GOT2—alcohol dependence	2.48e-05	0.000194	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GOT2—alcohol dependence	2.48e-05	0.000194	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ALDH2—alcohol dependence	2.48e-05	0.000194	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CNR1—alcohol dependence	2.45e-05	0.000192	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD4—alcohol dependence	2.44e-05	0.000191	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—DRD2—alcohol dependence	2.44e-05	0.000191	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR7—alcohol dependence	2.44e-05	0.000191	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD4—alcohol dependence	2.43e-05	0.00019	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—EP300—alcohol dependence	2.4e-05	0.000188	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—DRD2—alcohol dependence	2.39e-05	0.000187	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR7—alcohol dependence	2.39e-05	0.000187	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GGT2—alcohol dependence	2.39e-05	0.000187	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADH4—alcohol dependence	2.38e-05	0.000187	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—EP300—alcohol dependence	2.36e-05	0.000185	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CYP2E1—alcohol dependence	2.33e-05	0.000183	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CYP2E1—alcohol dependence	2.33e-05	0.000183	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CNR1—alcohol dependence	2.33e-05	0.000182	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CNR1—alcohol dependence	2.32e-05	0.000182	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NPY—alcohol dependence	2.31e-05	0.000181	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—EP300—alcohol dependence	2.31e-05	0.000181	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR2A—alcohol dependence	2.29e-05	0.000179	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR7—alcohol dependence	2.27e-05	0.000178	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD2—alcohol dependence	2.27e-05	0.000178	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD2—alcohol dependence	2.26e-05	0.000177	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR7—alcohol dependence	2.26e-05	0.000177	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.26e-05	0.000177	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—EP300—alcohol dependence	2.24e-05	0.000175	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AVP—alcohol dependence	2.23e-05	0.000175	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR1B—alcohol dependence	2.23e-05	0.000175	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CRH—alcohol dependence	2.23e-05	0.000175	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—EP300—alcohol dependence	2.23e-05	0.000175	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADH6—alcohol dependence	2.23e-05	0.000175	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.23e-05	0.000174	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADH7—alcohol dependence	2.22e-05	0.000174	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—EP300—alcohol dependence	2.22e-05	0.000174	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AVP—alcohol dependence	2.21e-05	0.000173	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD4—alcohol dependence	2.19e-05	0.000172	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADH1B—alcohol dependence	2.18e-05	0.000171	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—EP300—alcohol dependence	2.18e-05	0.00017	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADH7—alcohol dependence	2.17e-05	0.00017	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR2A—alcohol dependence	2.16e-05	0.000169	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR2A—alcohol dependence	2.16e-05	0.000169	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GOT1—alcohol dependence	2.14e-05	0.000168	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GGT1—alcohol dependence	2.14e-05	0.000168	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GGT1—alcohol dependence	2.14e-05	0.000168	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GOT1—alcohol dependence	2.14e-05	0.000168	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MAOB—alcohol dependence	2.14e-05	0.000167	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GGT2—alcohol dependence	2.13e-05	0.000167	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GOT2—alcohol dependence	2.11e-05	0.000165	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CNR1—alcohol dependence	2.09e-05	0.000164	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GGT2—alcohol dependence	2.08e-05	0.000163	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.07e-05	0.000162	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.06e-05	0.000162	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AVP—alcohol dependence	2.05e-05	0.000161	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	2.05e-05	0.00016	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR7—alcohol dependence	2.04e-05	0.00016	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD2—alcohol dependence	2.04e-05	0.00016	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—EP300—alcohol dependence	2.03e-05	0.000159	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADH7—alcohol dependence	2.03e-05	0.000159	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AVP—alcohol dependence	2.01e-05	0.000158	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—EP300—alcohol dependence	2.01e-05	0.000157	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—EP300—alcohol dependence	1.99e-05	0.000156	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CYP2E1—alcohol dependence	1.98e-05	0.000155	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—EP300—alcohol dependence	1.96e-05	0.000153	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD4—alcohol dependence	1.95e-05	0.000153	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADH1B—alcohol dependence	1.95e-05	0.000153	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GGT2—alcohol dependence	1.94e-05	0.000152	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—MAOA—alcohol dependence	1.92e-05	0.00015	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—MAOA—alcohol dependence	1.92e-05	0.00015	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AVP—alcohol dependence	1.91e-05	0.00015	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AVP—alcohol dependence	1.91e-05	0.000149	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADH1B—alcohol dependence	1.9e-05	0.000149	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CNR1—alcohol dependence	1.86e-05	0.000146	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.86e-05	0.000146	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR2A—alcohol dependence	1.86e-05	0.000146	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.85e-05	0.000145	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.84e-05	0.000144	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR2A—alcohol dependence	1.84e-05	0.000144	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—POMC—alcohol dependence	1.83e-05	0.000143	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GGT1—alcohol dependence	1.82e-05	0.000142	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GOT1—alcohol dependence	1.82e-05	0.000142	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR7—alcohol dependence	1.82e-05	0.000142	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD2—alcohol dependence	1.82e-05	0.000142	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ALDH2—alcohol dependence	1.82e-05	0.000142	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MAOB—alcohol dependence	1.81e-05	0.000142	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—EP300—alcohol dependence	1.79e-05	0.00014	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADH1B—alcohol dependence	1.78e-05	0.000139	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—POMC—alcohol dependence	1.73e-05	0.000135	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—POMC—alcohol dependence	1.72e-05	0.000135	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—EP300—alcohol dependence	1.72e-05	0.000135	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AVP—alcohol dependence	1.72e-05	0.000134	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR2A—alcohol dependence	1.71e-05	0.000134	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR2A—alcohol dependence	1.68e-05	0.000131	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MAOA—alcohol dependence	1.63e-05	0.000128	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MAOB—alcohol dependence	1.61e-05	0.000126	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR2A—alcohol dependence	1.59e-05	0.000125	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR2A—alcohol dependence	1.59e-05	0.000124	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MAOB—alcohol dependence	1.58e-05	0.000123	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADH4—alcohol dependence	1.57e-05	0.000123	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GOT2—alcohol dependence	1.54e-05	0.000121	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALDH2—alcohol dependence	1.54e-05	0.00012	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AVP—alcohol dependence	1.53e-05	0.00012	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—EP300—alcohol dependence	1.52e-05	0.000119	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—POMC—alcohol dependence	1.48e-05	0.000116	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.48e-05	0.000116	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MAOB—alcohol dependence	1.47e-05	0.000115	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—POMC—alcohol dependence	1.47e-05	0.000115	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CYP2E1—alcohol dependence	1.45e-05	0.000114	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR2A—alcohol dependence	1.43e-05	0.000112	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—EP300—alcohol dependence	1.4e-05	0.000109	CbGpPWpGaD
Regorafenib—BRAF—Disease—EP300—alcohol dependence	1.39e-05	0.000109	CbGpPWpGaD
Regorafenib—KIT—Immune System—EP300—alcohol dependence	1.37e-05	0.000108	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALDH2—alcohol dependence	1.37e-05	0.000107	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—POMC—alcohol dependence	1.36e-05	0.000107	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALDH2—alcohol dependence	1.34e-05	0.000105	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—POMC—alcohol dependence	1.34e-05	0.000105	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADH7—alcohol dependence	1.34e-05	0.000105	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GGT1—alcohol dependence	1.33e-05	0.000104	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GOT1—alcohol dependence	1.33e-05	0.000104	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.32e-05	0.000103	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GOT2—alcohol dependence	1.31e-05	0.000102	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—EP300—alcohol dependence	1.3e-05	0.000102	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—EP300—alcohol dependence	1.3e-05	0.000102	CbGpPWpGaD
Regorafenib—FGFR2—Disease—EP300—alcohol dependence	1.29e-05	0.000101	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGT2—alcohol dependence	1.28e-05	0.0001	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2A—alcohol dependence	1.27e-05	9.97e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—POMC—alcohol dependence	1.27e-05	9.95e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—EP300—alcohol dependence	1.27e-05	9.93e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—POMC—alcohol dependence	1.27e-05	9.92e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALDH2—alcohol dependence	1.25e-05	9.8e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—POMC—alcohol dependence	1.25e-05	9.79e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—POMC—alcohol dependence	1.25e-05	9.79e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CYP2E1—alcohol dependence	1.23e-05	9.63e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—EP300—alcohol dependence	1.21e-05	9.49e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.2e-05	9.42e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—EP300—alcohol dependence	1.2e-05	9.42e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—EP300—alcohol dependence	1.2e-05	9.4e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MAOA—alcohol dependence	1.19e-05	9.36e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.17e-05	9.17e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—EP300—alcohol dependence	1.17e-05	9.17e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GOT2—alcohol dependence	1.17e-05	9.14e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EP300—alcohol dependence	1.14e-05	8.97e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—POMC—alcohol dependence	1.14e-05	8.94e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—EP300—alcohol dependence	1.14e-05	8.94e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GOT2—alcohol dependence	1.14e-05	8.92e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GGT1—alcohol dependence	1.13e-05	8.84e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GOT1—alcohol dependence	1.13e-05	8.84e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CYP2E1—alcohol dependence	1.1e-05	8.59e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—EP300—alcohol dependence	1.08e-05	8.47e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.07e-05	8.39e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GOT2—alcohol dependence	1.06e-05	8.33e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—POMC—alcohol dependence	1.06e-05	8.31e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—EP300—alcohol dependence	1.04e-05	8.17e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—POMC—alcohol dependence	1.02e-05	7.97e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MAOA—alcohol dependence	1.01e-05	7.92e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GOT1—alcohol dependence	1.01e-05	7.89e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GGT1—alcohol dependence	1.01e-05	7.89e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CYP2E1—alcohol dependence	1e-05	7.83e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EP300—alcohol dependence	9.84e-06	7.71e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GOT1—alcohol dependence	9.83e-06	7.7e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GGT1—alcohol dependence	9.83e-06	7.7e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.81e-06	7.68e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EP300—alcohol dependence	9.75e-06	7.64e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MAOB—alcohol dependence	9.71e-06	7.6e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—EP300—alcohol dependence	9.63e-06	7.55e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GGT1—alcohol dependence	9.18e-06	7.19e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GOT1—alcohol dependence	9.18e-06	7.19e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EP300—alcohol dependence	9.04e-06	7.08e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MAOA—alcohol dependence	9.03e-06	7.07e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EP300—alcohol dependence	8.88e-06	6.95e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MAOA—alcohol dependence	8.81e-06	6.9e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	8.75e-06	6.86e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EP300—alcohol dependence	8.42e-06	6.6e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EP300—alcohol dependence	8.4e-06	6.58e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—EP300—alcohol dependence	8.29e-06	6.5e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—EP300—alcohol dependence	8.29e-06	6.5e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALDH2—alcohol dependence	8.25e-06	6.46e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MAOA—alcohol dependence	8.23e-06	6.45e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	7.98e-06	6.25e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—alcohol dependence	7.78e-06	6.09e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EP300—alcohol dependence	7.57e-06	5.93e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—EP300—alcohol dependence	7.04e-06	5.51e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT2—alcohol dependence	7.02e-06	5.5e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EP300—alcohol dependence	6.75e-06	5.28e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	6.6e-06	5.17e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—alcohol dependence	6.58e-06	5.16e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGT1—alcohol dependence	6.06e-06	4.74e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT1—alcohol dependence	6.06e-06	4.74e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—alcohol dependence	5.88e-06	4.6e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—alcohol dependence	5.74e-06	4.49e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MAOA—alcohol dependence	5.43e-06	4.25e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—alcohol dependence	5.36e-06	4.2e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—EP300—alcohol dependence	5.16e-06	4.04e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—EP300—alcohol dependence	4.37e-06	3.42e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—EP300—alcohol dependence	3.9e-06	3.05e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—EP300—alcohol dependence	3.81e-06	2.98e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—EP300—alcohol dependence	3.55e-06	2.78e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—alcohol dependence	3.53e-06	2.77e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—EP300—alcohol dependence	2.34e-06	1.84e-05	CbGpPWpGaD
